Search
for

    Glossary Hydroxyurea

    medication that inhibits DNA synthesis to treat cancer and blood disorders

    Hydroxyurea, also known as hydroxycarbamide, is a medication primarily used to treat certain types of cancer, such as chronic myelogenous leukemia, and blood disorders like sickle cell anemia. It works by inhibiting DNA synthesis, which helps to slow the growth of cancer cells and reduce the frequency of painful sickle cell crises.

    Research 10 of 228

    1. Nearly complete hair re-pigmentation in an older patient treated with hydroxyurea for essential thrombocytosis Journal of Oncology Pharmacy Practice · 2024 · 1 citations
    2. Fabrication and in vitro evaluation of silk fibroin-folic acid decorated paclitaxel and hydroxyurea nanostructured lipid carriers for targeting ovarian cancer cells: A double sword approach Journal of drug delivery science and technology · 2023 · 3 citations
    3. Mucocutaneous side effects of antineoplastic chemotherapy Expert opinion on drug safety · 2004 · 55 citations
    4. Psoriatic alopecia Clinical and Experimental Dermatology · 2015 · 41 citations
    5. Adverse cutaneous reactions to chemotherapeutic agents and cytokine therapy Seminars in Cutaneous Medicine and Surgery · 1996 · 18 citations
    6. Dermatological drugs, topical agents, and cosmetics Side effects of drugs annual · 2005 · 1 citations
    7. 523 Targeting NETosis to treat delayed wound healing in a humanized mouse model of sickle cell disease Journal of Investigative Dermatology · 2024
    8. Genital Dermatology Australasian Journal of Dermatology · 2022
    9. Hydrochlorothiazide/indometacin Reactions Weekly · 2009
    10. Features of steroidogenesis and arterial hypertension in men in different types of "physiological" male hyperandrogenism Problems of Endocrinology · 2023
    All research results →

    Learn

    — no results

    Try a deeper search in learn →

    Community

    — no results

    Try a deeper search in community →